🇺🇸 FDA
Patent

US 10584389

Cancer screening by detection of ultrastructural and molecular markers

granted A61PA61P35/00

Quick answer

US patent 10584389 (Cancer screening by detection of ultrastructural and molecular markers) held by Northwestern University expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P35/00